• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[骨质疏松症的流行病学]

[Epidemiology of osteoporosis].

作者信息

Éric Lespessailles

机构信息

Département de rhumatologie, centre hospitalier régional d'Orléans, université d'Orléans, EA 4708 - I3MTO Orléans, France.

出版信息

Rev Prat. 2020 Nov;70(9):1018-1022.

PMID:33739765
Abstract

Epidemiology of osteoporosis. Fragility fractures associated with osteoporosis have become increasingly common in women as early as age 55 and in men after age 65. These fractures cause substantial morbidity but also excess mortality and increasing health costs. The number of people aged 50 and over at high risk of fracture worldwide was estimated in 2010 at 158 million, and this number could double by 2040. In Europe, the total number of fragility fractures was 2.7 million in 2017 and could reach 3.3 million in 2030. Osteoporosis management is not optimal. There is a growing gap between the percentage of patients eligible for treatment and the percentage of patients treated. In France, even among patients who have had a fracture, the percentage of patients receiving treatment in the following year is less than 20%.

摘要

骨质疏松症的流行病学。与骨质疏松症相关的脆性骨折在女性中早在55岁时就越来越普遍,在男性中65岁以后也越来越常见。这些骨折不仅会导致严重的发病率,还会导致额外的死亡率和不断增加的医疗成本。2010年估计全球50岁及以上骨折高风险人群数量为1.58亿,到2040年这一数字可能会翻倍。在欧洲,2017年脆性骨折总数为270万,到2030年可能达到330万。骨质疏松症的管理并不理想。符合治疗条件的患者百分比与接受治疗的患者百分比之间的差距越来越大。在法国,即使在发生过骨折的患者中,次年接受治疗的患者百分比也不到20%。

相似文献

1
[Epidemiology of osteoporosis].[骨质疏松症的流行病学]
Rev Prat. 2020 Nov;70(9):1018-1022.
2
Epidemiology and economic burden of osteoporosis in Switzerland.瑞士的骨质疏松症流行病学和经济负担。
Arch Osteoporos. 2014;9:187. doi: 10.1007/s11657-014-0187-y. Epub 2014 Jun 27.
3
Fragility fractures in Europe: burden, management and opportunities.欧洲的脆性骨折:负担、管理和机会。
Arch Osteoporos. 2020 Apr 19;15(1):59. doi: 10.1007/s11657-020-0706-y.
4
Vertebral fractures cascade: potential causes and risk factors.脊柱骨折级联:潜在原因和危险因素。
Osteoporos Int. 2019 Mar;30(3):555-563. doi: 10.1007/s00198-018-4793-1. Epub 2018 Dec 5.
5
Fragility fractures in France: epidemiology, characteristics and quality of life (the EPIFRACT study).法国脆性骨折:流行病学、特征和生活质量(EPIFRACT 研究)。
Arch Osteoporos. 2020 Mar 13;15(1):46. doi: 10.1007/s11657-019-0674-2.
6
Real-world care for individuals aged over fifty with fractures in France: Evidence for a wide care gap-The EPIFRACT Study.法国五十岁以上骨折患者的真实世界护理:护理差距较大的证据——EPIFRACT 研究。
Joint Bone Spine. 2020 Oct;87(5):467-473. doi: 10.1016/j.jbspin.2020.04.007. Epub 2020 May 5.
7
The health and economic burden of osteoporotic fractures in Singapore and the potential impact of increasing treatment rates through more pharmacological options.新加坡骨质疏松性骨折的健康和经济负担,以及通过更多药物选择增加治疗率的潜在影响。
Arch Osteoporos. 2019 Nov 26;14(1):114. doi: 10.1007/s11657-019-0664-4.
8
Epidemiology and management of osteoporosis in the People's Republic of China: current perspectives.中华人民共和国骨质疏松症的流行病学与管理:当前观点
Clin Interv Aging. 2015 Jun 25;10:1017-33. doi: 10.2147/CIA.S54613. eCollection 2015.
9
Utilization of osteoporosis medication after a fragility fracture among elderly Medicare beneficiaries.老年医疗保险受益人群脆性骨折后骨质疏松症药物的使用情况。
Arch Osteoporos. 2016 Dec;11(1):31. doi: 10.1007/s11657-016-0285-0. Epub 2016 Sep 30.
10
Incidence of bone protection and associated fragility injuries in patients with proximal femur fractures.股骨近端骨折患者的骨保护及相关脆性损伤发生率。
Injury. 2017 Dec;48 Suppl 7:S27-S33. doi: 10.1016/j.injury.2017.08.035. Epub 2017 Aug 26.

引用本文的文献

1
Characteristics of subsequent contralateral proximal femoral fracture: more convenient access is needed to treat osteoporosis.后续对侧股骨近端骨折的特点:需要更方便的途径来治疗骨质疏松症。
J Orthop Surg Res. 2023 Feb 21;18(1):126. doi: 10.1186/s13018-023-03621-y.
2
Traditional Chinese Medicine as a Promising Strategy for the Treatment of Alzheimer's Disease Complicated With Osteoporosis.中医药作为治疗阿尔茨海默病合并骨质疏松症的一种有前景的策略。
Front Pharmacol. 2022 Jun 1;13:842101. doi: 10.3389/fphar.2022.842101. eCollection 2022.
3
Risk factors for hypocalcemia in dialysis patients with refractory secondary hyperparathyroidism after parathyroidectomy: a meta-analysis.
甲状旁腺切除术后难治性继发性甲状旁腺功能亢进透析患者低钙血症的危险因素:一项荟萃分析。
Ren Fail. 2022 Dec;44(1):503-512. doi: 10.1080/0886022X.2022.2048856.